Serge Belanger

Mr. Serge Belanger is a Managing Director at Needham & Co. LLC.
He joined Needham & Company in 2009, where he covers the specialty pharmaceuticals and biopharmaceuticals industries.
Prior to Needham, Mr. Belanger worked as a research associate at Fulcrum Global Partners and Susquehanna International Group covering the biotech and specialty pharma healthcare sectors.
Previously, he joined Adolor Corporation, a biopharmaceutical company, as a senior research scientist, where he was involved with the discovery and development of novel opioid receptor targeted molecules and non-opioid pain therapeutics.
He graduated from McGill University with a BSc, Biochemistry/Pharmacology, and an MSc, Pharmacology and Therapeutics.
He obtained his MBA in Finance from the Stern School of Business at New York University.